FDA approved immountherapy Opdivo (nivolumab) is a promising cancer drug treatment for different types of cancers, including melanoma, kidney cancer, lung cancer and Hodgkin lymphoma. In this video, oncologist Stephen Lemon MD talks about how this treatment helps to activate the patient’s immune system to fight back against the cancer.
Opdivo is developed by Bristol-Myers Squibb, Dr. Lemon with the Lighter Side of Cancer produces these videos to help provide more useful cancer information to patients and survivors. Dr. Lemon is not affiliated with Bristol-Myers Squibb.